Antitumor agents. 5. Synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5H-benzopyridophenoxazin-5-ones, and 5H-benzopyridophenoxazin-5-ones with potent antiproliferative activityBOLOGNESE, Adele; CORREALE, Gaetano; MANFRA, Michele et al.Journal of medicinal chemistry (Print). 2006, Vol 49, Num 17, pp 5110-5118, issn 0022-2623, 9 p.Article

Bevacizumab-related arterial hypertension as a predictive marker in metastatic colorectal cancer patientsDE STEFANO, Alfonso; CARLOMAGNO, Chiara; PEPE, Stefano et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 5, pp 1207-1213, issn 0344-5704, 7 p.Article

Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck regionSTAIBANO, Stefania; PEPE, Stefano; BIANCO, Angelo Raffaele et al.Human pathology. 2005, Vol 36, Num 7, pp 724-731, issn 0046-8177, 8 p.Article

Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27BALDASSARRE, Gustavo; BOCCIA, Angelo; VIGLIETTO, Giuseppe et al.Cell growth and differentiation. 2000, Vol 11, Num 10, pp 517-526, issn 1044-9523Article

BRAF is a therapeutic target in aggressive thyroid carcinomaSALVATORE, Giuliana; DE FALCO, Valentina; SALERNO, Paolo et al.Clinical cancer research. 2006, Vol 12, Num 5, pp 1623-1629, issn 1078-0432, 7 p.Article

Twenty-year results of the Naples GUN randomized trial: Predictive factors of adjuvant tamoxifen efficacy in early breast cancerDE PLACIDO, Sabino; DE LAURENTIIS, Michelino; PETTINATO, Guido et al.Clinical cancer research. 2003, Vol 9, Num 3, pp 1039-1046, issn 1078-0432, 8 p.Article

Correction of Hunter syndrome in the MPSII mouse model by AAV2/8-mediated gene deliveryCARDONE, Monica; POLITO, Vinicia Assunta; PEPE, Stefano et al.Human molecular genetics (Print). 2006, Vol 15, Num 7, pp 1225-1236, issn 0964-6906, 12 p.Article

Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)BIANCO, Cataldo; TORTORA, Giampaolo; PEPE, Stefano et al.Clinical cancer research. 2002, Vol 8, Num 10, pp 3250-3258, issn 1078-0432, 9 p.Article

A Specific miRNA Signature Correlates With Complete Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerDELLA VITTORIA SCARPATI, Giuseppina; FALCETTA, Francesca; CARLOMAGNO, Chiara et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 4, pp 1113-1119, issn 0360-3016, 7 p.Article

Predictive Factors of Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal CancerCARLOMAGNO, Chiara; PEPE, Stefano; D'ARMIENTO, Francesco Paolo et al.Oncology. 2010, Vol 78, Num 5-6, pp 369-375, issn 0030-2414, 7 p.Article

Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-α in head and neck cancer cells in vitro and in vivoBRUZZESE, Francesca; DI GENNARO, Elena; AVALLONE, Antonio et al.Clinical cancer research. 2006, Vol 12, Num 2, pp 617-625, issn 1078-0432, 9 p.Article